Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy
Journal for ImmunoTherapy of Cancer
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients